Kanmin Xue

Kanmin Xue is an Associate Professor at the University of Oxford and Honorary Consultant Vitreoretinal Surgeon at Oxford Eye Hospital and Great Ormond Street Hospital. He leads the Retinal Disease and Repair Group and holds a Wellcome Trust Clinician Scientist Fellowship. Previously, he served as an NIHR Academic Clinical Lecturer (2014-2018) and completed vitreoretinal training at Royal Victorian Eye and Ear Hospital in Melbourne.

Education:

• PhD at MRC Laboratory of Molecular Biology, Cambridge
• Clinical training at Trinity College Cambridge
• Pre-clinical training at Brasenose College Oxford (Martin Wronker Prize recipient)

His research focuses on retinal degeneration mechanisms in age-related macular degeneration and uveitis, developing novel therapies including viral/non-viral gene delivery, gene editing, and AI applications. The work integrates patient studies, clinical trials, and artificial intelligence for clinical translation.

Publication trends show concentrated work in retinal gene therapy (35%), AI/telemedicine applications (25%), inflammatory eye diseases (20%), and pediatric ophthalmology (20%), with recent emphasis on transcriptomics and AI-driven clinical tools.

Awards:

• Ruskell Medal (2019)
• Ian Fraser Cup (2017)
• Luigi Barca Award (2017)
• Martin Wronker Prize (2003)
• Early Career Researcher Award (2024)

He currently advises 6 doctoral candidates and has supervised 6 past students. Major funding includes the Wellcome Trust Career Development Fellowship. Leads the Retinal Disease and Repair Lab (Xue Lab) and collaborates with Prof. Robert MacLaren's team on gene therapy and surgical innovation.